CONTRAST INDUCED ACUTE KIDNEY INJURY

Clinical trials for CONTRAST INDUCED ACUTE KIDNEY INJURY explained in plain language.

Never miss a new study

Get alerted when new CONTRAST INDUCED ACUTE KIDNEY INJURY trials appear

Sign up with your email to follow new studies for CONTRAST INDUCED ACUTE KIDNEY INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 3

New drug aims to shield kidneys from dye damage during heart surgery

Disease control Ongoing

This study tests whether the drug APX-115 can prevent kidney injury caused by contrast dye used in heart procedures. About 230 adults with kidney disease will receive either the drug or a placebo before and after their procedure. The goal is to see if the drug reduces kidney dama…

Matched conditions: CONTRAST INDUCED ACUTE KIDNEY INJURY

Phase: PHASE2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

CONTRAST INDUCED ACUTE KIDNEY INJURY

Get alerted when new CONTRAST INDUCED ACUTE KIDNEY INJURY trials appear

New drug aims to shield kidneys from dye damage during heart surgery